Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol

INTRODUCTION: Standard treatment for nodular/bronchiectatic Mycobacterium avium complex lung disease (NB MAC-LD), excluding severe-status cases, differs between Japan and other countries. Internationally, three-drug combination intermittent treatment (three times a week administration) with macrolid...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Taku, Hashimoto, Hiroya, Yagi, Mitsuaki, Kogure, Yoshihito, Sekimizu, Masahiro, Saito, Akiko M, Ogawa, Kenji, Inoue, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Respiratory Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561383/
https://www.ncbi.nlm.nih.gov/pubmed/31258920
http://dx.doi.org/10.1136/bmjresp-2019-000434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561383/
https://www.ncbi.nlm.nih.gov/pubmed/31258920
http://dx.doi.org/10.1136/bmjresp-2019-000434

Ejemplares similares